Antibiotice
Antibiotice S.A., a prominent player in the pharmaceutical industry, is headquartered in Iaşi, Romania. Established in 1955, the company has evolved into a leading manufacturer of generic antibiotics and other essential medications, serving both domestic and international markets. With a strong focus on research and development, Antibiotice has achieved significant milestones, including the production of innovative formulations and a robust portfolio of over 200 products. The company’s core offerings include injectable antibiotics, oral medications, and topical treatments, distinguished by their high quality and efficacy. Antibiotice is recognised for its commitment to sustainability and compliance with international standards, positioning itself as a trusted partner in healthcare. With a solid market presence in Europe and beyond, Antibiotice continues to contribute to global health through its dedication to pharmaceutical excellence.
DitchCarbon Score
How does Antibiotice's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Antibiotice's score of 24 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Antibiotice's reported carbon emissions
In 2021, Antibiotice reported total carbon emissions of approximately 11,203,000 kg CO2e. This figure includes 9,626,410 kg CO2e from Scope 1 emissions, primarily from stationary and mobile combustion, and 2,773,000 kg CO2e from Scope 2 emissions, which are related to purchased electricity. In 2022, the company achieved a reduction in total emissions to about 9,937,240 kg CO2e, with Scope 1 emissions at 8,947,850 kg CO2e and Scope 2 emissions based on a market-based approach at 0 kg CO2e. This indicates a significant commitment to reducing their carbon footprint. Antibiotice has set near-term climate targets and is actively engaged in initiatives to lower emissions, although they have not committed to a net-zero target as of now. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector and is based in Romania. Their ongoing efforts reflect a commitment to sustainability and climate responsibility in their operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 9,141,900 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,604,070 | 0,000,000 | 0,000,000 | - |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Antibiotice is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
